We use first- and third-party cookies to provide our services and collect statistical data. By continuing to browse you accept these cookies. More information Accept
Expertise / DIFFERENTIATED PRODUCTS / Therapeutic Areas

therapeutic areas

We are the leaders offering the most therapeutic options in*
  • epilepsy
  • parkinson's
  • antipsychotics
  • depression
  • alzheimer's
and we continue to grow in other therapies
(*) Source: MIDAS Q2/2017

our portfolio

of marketed cns molecules

> 100 molecules

23%
Antidepressants
23%
Antipsychotics
12%
Antiepileptics
12%
Antiparkinson
12%
other
7%
analgesics
7%
anxiolytics / hypnotics
6%
antidementia

NuPharm Group,
a strategic
alliance in CNS